Form TA-1/A BNY Mellon International
Tweet
Share
E-mailhttp://archive.fast-edgar.com/20260408/ABZ2N22CZ22252W2222P22Z2MNUTSS2S7282
Filed on: April 3, 2026
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Apeing’s $0.0004 Stage 3 Price Fuels the Million-Maker Hunt: 5 Best Meme Coins to Buy for Massive Upside
- Tigo Energy Drives Growth for UK Installers With Training, Support, and 211GWh in Optimization
- U.S. FDA grants Priority Review for Roche’s Enspryng for MOGAD, an autoimmune disease with no approved treatments
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
